HK1231493A1 - 药学上相关的芳香族阳离子肽 - Google Patents

药学上相关的芳香族阳离子肽 Download PDF

Info

Publication number
HK1231493A1
HK1231493A1 HK17105171.1A HK17105171A HK1231493A1 HK 1231493 A1 HK1231493 A1 HK 1231493A1 HK 17105171 A HK17105171 A HK 17105171A HK 1231493 A1 HK1231493 A1 HK 1231493A1
Authority
HK
Hong Kong
Prior art keywords
cationic peptides
pharmaceutically relevant
peptides
relevant aromatic
phe
Prior art date
Application number
HK17105171.1A
Other languages
English (en)
Chinese (zh)
Inventor
D Travis Wilson
Original Assignee
Stealth Biotherapeutics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stealth Biotherapeutics Corp filed Critical Stealth Biotherapeutics Corp
Publication of HK1231493A1 publication Critical patent/HK1231493A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1021Tetrapeptides with the first amino acid being acidic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0815Tripeptides with the first amino acid being basic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0815Tripeptides with the first amino acid being basic
    • C07K5/0817Tripeptides with the first amino acid being basic the first amino acid being Arg
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1016Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK17105171.1A 2014-03-03 2014-12-23 药学上相关的芳香族阳离子肽 HK1231493A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461947286P 2014-03-03 2014-03-03
US201461947286P 2014-03-03
PCT/US2014/072267 WO2015134096A1 (en) 2014-03-03 2014-12-23 Pharmaceutically relevant aromatic-cationic peptides

Publications (1)

Publication Number Publication Date
HK1231493A1 true HK1231493A1 (zh) 2017-12-22

Family

ID=54055710

Family Applications (1)

Application Number Title Priority Date Filing Date
HK17105171.1A HK1231493A1 (zh) 2014-03-03 2014-12-23 药学上相关的芳香族阳离子肽

Country Status (7)

Country Link
US (1) US20170081363A1 (https=)
EP (1) EP3114136A4 (https=)
JP (1) JP2017512762A (https=)
CN (1) CN106459169A (https=)
CA (1) CA2942143A1 (https=)
HK (1) HK1231493A1 (https=)
WO (1) WO2015134096A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6626446B2 (ja) * 2013-12-27 2019-12-25 ステルス バイオセラピューティックス コープ 薬学的に適切な芳香族カチオン性ペプチド
US10633415B2 (en) 2015-03-06 2020-04-28 Stealth Biotherapeutics Corp Processes for preparing pharmaceutically relevant peptides
JPWO2017043626A1 (ja) * 2015-09-11 2018-06-21 株式会社カネカ 光学活性4−カルバモイル−2,6−ジメチルフェニルアラニン誘導体の製造法
CA3020393A1 (en) 2016-04-11 2017-10-19 Carnot, Llc Chiral peptides
CN110914287A (zh) 2017-04-05 2020-03-24 隐形生物治疗公司 Boc-d-arg-dmt-lys-(boc)-phe-nh2的结晶盐形式
US20200361987A1 (en) * 2017-11-15 2020-11-19 Stealth Biotherapeutics Corp. Deuterated tetrapeptides that target mitochondria
US10676506B2 (en) 2018-01-26 2020-06-09 Stealth Biotherapeutics Corp. Crystalline bis- and tris-hydrochloride salt of elamipretide
EP3898653A4 (en) 2018-12-18 2022-08-24 Stealth BioTherapeutics Inc. ANALOGS TARGETING MITOCHONDRIAL DISEASES
TW202346255A (zh) * 2022-01-06 2023-12-01 日商中外製藥股份有限公司 醯胺化合物的製造方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214663B2 (en) * 2000-06-14 2007-05-08 Medarex, Inc. Tripeptide prodrug compounds
JP4879020B2 (ja) * 2003-05-01 2012-02-15 コーネル リサーチ ファウンデイション インコーポレイテッド 細胞に分子を送達する方法及び担体複合体
US20070213505A1 (en) * 2006-03-08 2007-09-13 David Epstein Solution Synthesis of Peptide Cell Growth Stimulators
EP3375449A1 (en) * 2010-03-15 2018-09-19 Stealth Peptides International, Inc. Combination therapies using cyclosporine and aromatic cationic peptides
AU2012271691A1 (en) * 2011-06-14 2014-01-16 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
HK1204988A1 (en) * 2012-02-22 2015-12-11 Stealth Peptides International, Inc. Methods and compositions for preventing or treating ophthalmic conditions
EP2928562A4 (en) * 2012-12-06 2016-06-22 Stealth Peptides Int Inc PEPTIDE THERAPEUTIC PRODUCTS AND METHODS OF USE

Also Published As

Publication number Publication date
CN106459169A (zh) 2017-02-22
EP3114136A1 (en) 2017-01-11
US20170081363A1 (en) 2017-03-23
JP2017512762A (ja) 2017-05-25
WO2015134096A1 (en) 2015-09-11
CA2942143A1 (en) 2015-09-11
EP3114136A4 (en) 2017-11-01

Similar Documents

Publication Publication Date Title
HK1231493A1 (zh) 药学上相关的芳香族阳离子肽
PL3531852T3 (pl) System wytwarzania aerozolu, zastosowanie materiału zużywalnego w systemie i sposób wytwarzania aerozolu
MX2020004073A (es) Procesos de siembra en serie y usos de los mismos.
SG10201803042PA (en) Anti-tim-3 antibodies
SG10201804931QA (en) Anti-cll-1 antibodies and immunoconjugates
WO2015179691A3 (en) Cell penetrating peptides and methods of making and using thereof
EP3200812A4 (en) Novel 4 7 peptide monomer and dimer antagonists
AU2015286721B2 (en) Influenza virus vaccines and uses thereof
SG10201808259TA (en) Anti-jagged1 antibodies and methods of use
EP3250240A4 (en) Dimeric collagen hybridizing peptides and methods of using
WO2016125192A3 (en) Processes for the preparation of dolute-gravir
AU2015352158A8 (en) Medicaments for slowing Parkinson's Disease
PH12016501689B1 (en) Tatk-cdkl5 fusion proteins, compositions, formulations, and use thereof
HK1223298A1 (zh) 预防和治疗组织损伤相关疾病和病症的组织保护肽和肽类似物
EP3237374A4 (en) Amino acid and peptide conjugates and uses thereof
MX2016013589A (es) Composiciones que comprenden derivados de osteopontina para la inhibicion del crecimiento de pelo.
EP3263584A4 (en) Peptide for targeting autophagic cells and use thereof
EP3341739A4 (en) MUTATED PEPTIDES AND METHOD FOR TREATING SUBJECTS THEREWITH
EP3230301A4 (en) Gpc3 epitope peptides for th1 cells and vaccines containing the same
AU359863S (en) Endoscope system workstation
EP3240540A4 (en) Hdac1,2 inhibitors and methods of using the same
EP3166406A4 (en) Cytokine-chitosan bioconjugates and methods of using the same
PL3526244T3 (pl) Peptydy pochodzące z propeptydu ntsr3 i ich zastosowanie w leczeniu depresji
EP3288963A4 (en) Pink1 c-terminal domain polypeptide and methods using the same in cancer treatment
EP3180021A4 (en) Myristoylated leptin-related peptides and uses thereof